Literature DB >> 10482481

Quantitative evaluation of "sunset glow" fundus in Vogt-Koyanagi-Harada disease.

S Suzuki1.   

Abstract

PURPOSE: To evaluate the color of the fundus quantitatively, especially the "sunset glow" fundus, in patients with Vogt-Koyanagi-Harada (VKH) disease.
METHODS: The fundus of 39 patients (13 men and 26 women) who were diagnosed with VKH disease were photographed. The photographs were scanned by a film scanner and the amount of red, green, and blue pixels making up the image was determined by image analyzing software. A "sunset glow" index, the ratio of the number of red pixels to the total number of pixels, was determined for all patients as well as 31 normal controls.
RESULTS: In comparison to the controls, the "sunset glow" indices at 3 months after onset of the "sunset glow" fundus showed significant increases in VKH patients. Six months after onset, the "sunset glow" indices showed further significant increases and continued to increase during the course of the disease.
CONCLUSIONS: The depigmentary changes can be found earlier by using our method rather than ophthalmoscopy. Because our method is more sensitive for slight depigmentary changes, the pigmentary changes in the fundus could be found in all the VKH patients. This quantitative evaluation of the fundus makes a correct diagnosis possible even in patients who do not demonstrate the "sunset glow" fundus by normal ophthalmoscopic examinations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482481     DOI: 10.1016/s0021-5155(99)00016-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  21 in total

1.  Quantitative analysis of myopic chorioretinal degeneration using a novel computer software program.

Authors:  Kumari Neelam; Rebecca Y K Chew; Martin H K Kwan; Chee Chew Yip; Kah-Guan Au Eong
Journal:  Int Ophthalmol       Date:  2012-04-06       Impact factor: 2.031

2.  Sex judgment using color fundus parameters in elementary school students.

Authors:  Saki Noma; Takehiro Yamashita; Ryo Asaoka; Hiroto Terasaki; Naoya Yoshihara; Naoko Kakiuchi; Taiji Sakamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-16       Impact factor: 3.117

3.  Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.

Authors:  Kei Nakai; Fumi Gomi; Yasushi Ikuno; Yoshiaki Yasuno; Takeyoshi Nouchi; Nobuyuki Ohguro; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-13       Impact factor: 3.117

4.  MR findings of the orbit in patients with Vogt-Koyanagi-Harada disease.

Authors:  Tomohiro Ando; Hiroki Kato; Kiyofumi Mochizuki; Kenji Ozawa; Satoshi Goshima; Masayuki Matsuo
Journal:  Neuroradiology       Date:  2018-02-23       Impact factor: 2.804

5.  Factors associated with optic nerve head blood flow and color tone: a retrospective observational study.

Authors:  Yoshimasa Kuroda; Akihito Uji; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-04       Impact factor: 3.117

6.  Visual function in Vogt-Koyanagi-Harada patients.

Authors:  Soon-Phaik Chee; Chi D Luu; Ching-Li Cheng; Wee-Kiak Lim; Aliza Jap
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-11       Impact factor: 3.117

7.  Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: differentiation between choroidal scars and active lesions.

Authors:  Pascal B Knecht; Alessandro Mantovani; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-01-01       Impact factor: 2.031

8.  A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.

Authors:  Eun Kyoung Lee; Sang-Yoon Lee; Hyeong Gon Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-15       Impact factor: 3.117

9.  Quantitative comparison of disc rim color in optic nerve atrophy of compressive optic neuropathy and glaucomatous optic neuropathy.

Authors:  Eri Nakano; Masayuki Hata; Akio Oishi; Kazuaki Miyamoto; Akihito Uji; Masahiro Fujimoto; Manabu Miyata; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-26       Impact factor: 3.117

10.  Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.

Authors:  Tatsushi Kawaguchi; Shintaro Horie; Nadia Bouchenaki; Kyoko Ohno-Matsui; Manabu Mochizuki; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2009-01-17       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.